Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
Status:
Terminated
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving boron phenylalanine in different ways and measuring it in tissue in
patients with glioblastoma multiforme may help in planning better radiation therapy, such as
boron neutron capture therapy, for patients in the future.
PURPOSE: This phase I trial is studying the side effects, best dose boron phenylalanine, and
best way of giving it with or without mannitol in treating patients with glioblastoma
multiforme.